Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) [Phase 2, Phase 3]
Clinical trial update for COMPANION-002 evaluating CTX-009 in combination with Paclitaxel in adults with unresectable or metastatic biliary …
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma [Phase 2, Phase 3]
Phase 2/3 trial evaluating whether [18F] F-FAPI PET-CT changes management in proximal cholangiocarcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
This clinical trial update describes the collection of blood and tissue samples from patients with primary liver cancer to support research.…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer [Phase 3]
Phase 3 trial evaluating adjuvant chemotherapy with gemcitabine and cisplatin versus standard of care after curative resection of biliary tr…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma [Phase 2]
This clinical trial update describes a Phase 2 neoadjuvant regimen of tislelizumab, gemcitabine, cisplatin, and S-1 for resectable high-risk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy [Phase 4]
Phase 4 clinical trial evaluating radiofrequency ablation or photodynamic therapy for non-resectable hilar cholangiocarcinoma; currently rec…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma
Clinical trial update investigating CD24 expression as a potential 'do-not-eat-me' signal in cholangiocarcinoma.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer [Phase 2]
Phase 2 clinical trial evaluating Taxol (paclitaxel) given intravenously and intraperitoneally with Tasigna (nilotinib) taken orally for per…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
This clinical trial update discusses a noninvasive breath test being studied to detect liver cancer and monitor liver conditions, with recru…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence [Phase 2, Phase 3]
Clinical trial update for a Phase 2/3 study evaluating preoperative Cisplatin, Gemcitabine, and Nab-paclitaxel (GAP) versus immediate resect…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy [NA]
This update describes an ongoing clinical trial evaluating a geriatric intervention for frail patients with gastric, biliary tract (cholangi…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial at Siriraj Hospital is evaluating modified autologous cytokine-induced killer (CIK) cell immunothe…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma [Phase 3]
A Phase 3 clinical trial is evaluating a quadruple therapy regimen with lenvatinib, tislelizumab, gemcitabine, and cisplatin (GPLET) for adv…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
This clinical trial update notes that an early-stage detection study for liver cancer, biliary tract cancer, and pancreatic cancer is curren…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma
An ongoing clinical trial is evaluating a combination of chemotherapy, immunotherapy, and targeted therapy for cholangiocarcinoma, and is cu…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT) [Phase 1, Phase 2]
A multicenter, open-label Phase Ib/II trial evaluating first-line trastuzumab with gemcitabine and cisplatin plus nivolumab in HER2-positive…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples
This clinical trial is investigating cell-surface plectin as a diagnostic biomarker for cholangiocarcinoma using ERCP-derived biliary sample…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer [Phase 2]
This Phase 2 trial evaluates neoadjuvant gemcitabine plus cisplatin, with or without durvalumab, in patients with resectable biliary tract c…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk [Phase 2]
Phase 2 trial evaluating donafenib in combination with capecitabine as postoperative adjuvant therapy for biliary tract cancer with high rec…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE [Phase 2]
Phase 2 ACHIEVE trial evaluating adjuvant combination of Adebrelimab (SHR-1316) and Capecitabine in high-risk resected cholangiocarcinoma; r…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
An observational study evaluating intra-arterial therapies for primary liver diseases, including hepatocellular carcinoma and cholangiocarci…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.
A retrospective study examined risk factors in patients undergoing pancreaticoduodenectomy and developed a nomogram to standardize PD surgic…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: TAS102 in Combination With NAL-IRI in Advanced GI Cancers [Phase 1, Phase 2]
This document provides an update on an ongoing Phase 1/2 clinical trial evaluating the combination of TAS-102 with nanoliposomal irinotecan …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours [NA]
This clinical trial registry entry describes a study evaluating the diagnostic value of next-generation sequencing analysis in biliary tract…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors [Phase 2]
Phase 2 trial of Utidelone as monotherapy for advanced solid tumors, currently not recruiting.